期刊文献+

可益能治疗老年性痴呆28例疗效观察

下载PDF
导出
摘要 目的:评价可益能(左旋卡尼汀,LC)治疗轻、中度卡尼汀缺乏病人的疗效。方法:选择轻中度Alzheimer病人56例,按双盲设计,患者随机分为2组,治疗组应用LC治疗(每次2g,2次/d),安慰剂组(对照组)应用安慰剂治疗,疗程60d,LC与安慰剂外观包装相同。60d后评价疗效。结果:治疗组在认知功能、病程进展程度以及临床总体疗效改善率显著高于对照组(P<0.01)。结论:可益能在治疗老年性痴呆方面其病程发展以及病情改善有显著作用。
作者 靳贵生
出处 《医学理论与实践》 2007年第8期907-908,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献5

  • 1Matsuoka M,Igisu H.Comparison of the effects of L-carnitine,D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia[J].Biochem Pharmacol,1993,46(1):159-164.
  • 2Mckhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer's disease:report of the NINCDS/ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease[J].Neurology,1984,34(7):939-944.
  • 3Mariano Malaguarnera,Giovanni Pistone,Rampello Elvira,Carmelo Leotta,Linda Scarpello,Rampello Liborio.Effects of L-carnitine in patients with hepatic encephalopathy[J].World Journal of Gastroenterology,2005,11(45):7197-7202. 被引量:14
  • 4Launer LJ,Andersen K,Dewey ME,et al.Rates and risk factors for dementia and Alzheimer disease[J].Neurology,1999,52:78-82.
  • 5Rai G,Wright G,Scott L,Double-blind,placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia[J].Curr Med Res Opin,1990,11 (10):638-647.

二级参考文献32

  • 1[29]Hearn TJ,Coleman AE,Lai JC,Griffith OW,Cooper AJ.Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portacaval-shunted rats.Hepatology 1989; 10:822-828
  • 2[30]Therrien G,Giguere JF,Butterworth RF.Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.Metab Brain Dis 1991; 6:231-238
  • 3[31]Sherratt HS.Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates.Biochem Soc Trans 1985; 13:856-858
  • 4[32]Corkey BE,Hale DE,Glennon MC,Kelley RI,Coates PM,Kilpatrick L,Stanley CA.Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome.J Clin Invest 1988; 82:782-788
  • 5[1]Lockwood AH,Yap EW,Wong WH Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.J Cereb Blood Flow Metab 1991; 11:337-341
  • 6[2]Blei AT.Brain oedema and portal-systemic encephalopathy.Liver Transpl.2000; 6:S14-20
  • 7[3]O'Connor JE,Costell M,Grisolia S.Prevention of ammonia toxicity by L-carnitine:metabolic changes in brain.Neurochem Res 1984; 9:563-570
  • 8[4]Therrien G,Rose C,Butterworth J,Butterworth RF.Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.Hepatology 1997; 25:551-556
  • 9[5]Matsuoka M,Igisu H,Kohriyama K,Inoue N.Suppression of neurotoxicity of ammonia by L-carnitine.Brain Res.1991; 567:328-331
  • 10[6]Malaguarnera M,Pistone G,Astuto M,Dell'Arte S,Finocchiaro G,Lo Giudice E,Pennisi G.L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.Dig Dis 2003; 21:271-275

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部